BRIAN WIEDERHOLD: Open Payments
NPI 1851090237 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 75 payments from 14 companies in 2025. Trend: 2023 $48 · 2024 $754 · 2025 $1,593
Food & beverage: $1,510Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $345 |
| Incyte Corporation | 20 | $269 |
| Regeneron Healthcare Solutions, Inc. | 6 | $213 |
| ABBVIE INC. | 9 | $178 |
| GENZYME CORPORATION | 7 | $168 |
| LNHC, Inc | 5 | $167 |
| UCB, Inc. | 5 | $100 |
| Amgen Inc. | 1 | $29 |
| Organon LLC | 4 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: DUPIXENT, TREMFYA, OPZELURA, ZELSUVMI, SKYRIZI, Bimzelx, RINVOQ, OTEZLA.
Industry payments across FL — which companies pay providers there.
